phase readout
saveNCT07214532: Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
RECRUITINGupdated 12m ago
community read0 votes
Sponsor: Natera, Inc.. Phase: NA. Conditions: Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)
view source ↗
comments(0)
5-min edit window · permanent after that